title: Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice.
abstract: The effects of long-term chronic growth hormone (GH) excess on lipid and lipoprotein metabolism were investigated in 8-mo-old bovine GH (bGH)-transgenic mice. Total body weight, serum cholesterol, insulin-like growth factor-I, and insulin levels were higher, whereas serum levels of glucose, free fatty acids, and triglycerides were lower in transgenic mice. Very low-density lipoprotein (VLDL) cholesterol levels were lower, and low-density lipoprotein (LDL) cholesterol levels were higher, in transgenic mice irrespective of gender, whereas only transgenic male mice had higher high-density lipoprotein cholesterol levels. Total serum apolipoprotein B (apoB) levels were not affected, but the amount of apoB in the LDL fraction was higher in transgenic mice. Hepatic LDL receptor expression was unchanged, whereas apoB mRNA editing and hepatic triglyceride secretion rate were reduced in bGH-transgenic male mice. Both lipoprotein lipase activity in adipose and heart tissue and beta-adrenergic-stimulated lipolysis were increased in transgenic male mice. The relative weight of adipose tissue was lower in transgenic mice, whereas hepatic triglyceride content was unchanged. Fat feeding of the mice equalized serum triglycerides and free fatty acids in bGH-transgenic and control mice. In summary, long-term GH excess is associated with marked alterations in lipid and lipoprotein metabolism, indicating decreased production and increased degradation of VLDL and preferential flux of fatty acids to muscle tissues.
authors.affiliation: Department of Physiology, Göteborg University, 405 30 Goteborg, Sweden. Fredrik.Frick@fysiologi.gu.se
authors.forename: F
authors.initials: F
authors.lastname: Frick
authors.forename: M
authors.initials: M
authors.lastname: Bohlooly-Y
authors.forename: D
authors.initials: D
authors.lastname: Lindén
authors.forename: B
authors.initials: B
authors.lastname: Olsson
authors.forename: J
authors.initials: J
authors.lastname: Törnell
authors.forename: S
authors.initials: S
authors.lastname: Edén
authors.forename: J
authors.initials: J
authors.lastname: Oscarsson
mesh_terms: D000818:Animals; D001055:Apolipoproteins B / Q000096:biosynthesis; D001786:Blood Glucose / Q000378:metabolism; D015153:Blotting, Western; D001835:Body Weight / Q000502:physiology; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D013006:Growth Hormone / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D007328:Insulin / Q000096:biosynthesis; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis; D008066:Lipolysis / Q000235:genetics / Q000502:physiology; D008071:Lipoprotein Lipase / Q000378:metabolism; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009929:Organ Size / Q000502:physiology; D017393:RNA Editing; D012333:RNA, Messenger / Q000096:biosynthesis; D011973:Receptors, LDL / Q000096:biosynthesis; D014280:Triglycerides / Q000097:blood / Q000378:metabolism
chemical_list: D001055:Apolipoproteins B; D001786:Blood Glucose; D007328:Insulin; D008074:Lipoproteins; D012333:RNA, Messenger; D011973:Receptors, LDL; D014280:Triglycerides; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D002784:Cholesterol; D008071:Lipoprotein Lipase